Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000335144 | SCV000344720 | uncertain significance | not provided | 2016-08-08 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001171071 | SCV001333741 | benign | Cardiomyopathy | 2018-04-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001441657 | SCV001644588 | likely benign | Desmin-related myofibrillar myopathy | 2022-12-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000335144 | SCV002584007 | uncertain significance | not provided | 2023-02-27 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30564623, 26807690) |
Ambry Genetics | RCV003352824 | SCV004056232 | benign | Cardiovascular phenotype | 2023-09-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004742370 | SCV005353624 | likely benign | DES-related disorder | 2024-09-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |